News and press releases from HAPILA
CPhI Worldwide 2016 in Barcelona
"CPhI is an established pharmaceutical event with over 26 years' experience of bringing together the movers and shakers in pharma."This year the CPhI Worldwide exhibition takes place from 4th-6th October, 2016 at the...[more]
Strategic Advisory Board is Extended
In the course of this year‘s 7th conference the advisory board of HAPILA GmbH was extended. It means a great pleasure to us to welcome Prof. Dr. Dr. Gerhard Strugala as a new member of the advisory board. We hope for additional...[more]
US Patent for Counter-current Crystallization HAPIpur®
Effective from 4 August 2015, we have been granted the US patent with the registration number US 9,095,783 "Arrangement and method for producing high-purity crystals" by the American patent office "United States...[more]
Come and see us at the CPhl 2015 in Madrid
HAPILA GmbH participates in the CPhl Worldwide this year as an exhibitor for the eighth time. We invite you to see us at our stall 9C11 to talk to us about existing or new projects concerning development and GMP manufacture in...[more]
CEP Grant by the European Medicines Agency
Recently the EDQM (European Directorate for the Quality of Medicines & Health Care, headquarters in Strasbourg) granted us the Certificate of suitability No. R0-CEP 2013-277 (Certification of suitability of Monographs of the...[more]
Exhibitor at ACHEMA 2015 Frankfurt am Main
HAPILA will be present at the ACHEMA – World Forum and 31. Leading Show for the Process Industries at hall 5.1 stand C73. The 2015 exhibition with expected 3,800 exhibitors from 50 countries takes place on 15-19 June 2015 in...[more]
HAPILA at the CPhI Worldwide 2014 in Paris
For the seventh time already, HAPILA GmbH has participated in the CPhI Worldwide exhibition which is the most important one for us, having a joint booth of the network 4chiral. This year the CPhI Worldwide exhibition took...[more]